| Quarter (USD) | Mar 21 | Dec 20 | Sep 20 | Jun 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 20 | Dec 19 | Dec 18 | Dec 17 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 44.85 mm | 44.85 mm | 44.85 mm | 44.85 mm | 44.85 mm | 44.85 mm |
| Cash burn (monthly) | (no burn) | (no burn) | 10.17 mm | 7.49 mm | 6.88 mm | 6.95 mm |
| Cash used (since last report) | n/a | n/a | 470.10 mm | 346.39 mm | 318.23 mm | 321.33 mm |
| Cash remaining | n/a | n/a | -425.25 mm | -301.54 mm | -273.38 mm | -276.48 mm |
| Runway (months of cash) | n/a | n/a | -41.8 | -40.3 | -39.7 | -39.8 |
| 13F holders | Current |
|---|---|
| Total holders | 1 |
| Opened positions | 0 |
| Closed positions | 0 |
| Increased positions | 0 |
| Reduced positions | 0 |
| 13F shares | Current |
|---|---|
| Total value | 30.97 mm |
| Total shares | 7.12 mm |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| MPM BioVentures IV QP | 7.12 mm | $30.97 mm |
